FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics, and can be used for prophylaxis of severe gestosis. For this purpose to patients with severe gestosis in anamnesis, starting with the 3-rd week of pregnancy "Microfollin" is administered in dose 0.05 mg daily until the 10-th week of pregnancy and medication "Dufaston" in dose 30 mg daily until the 140th week of pregnancy.
EFFECT: method makes it possible to increase efficiency of preventive measures against severe gestosis due to improvement of microhemodynamics and normalisation of immune response.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREECLAMPSIA PREVENTION | 2018 |
|
RU2682167C1 |
METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
METHOD FOR COAGULOPATIC BLEEDING PREVENTION DURING CESAREAN SECTION | 2016 |
|
RU2629040C1 |
METHOD FOR PREVENTING LATE TOXICOSIS OF PREGNANCY | 1995 |
|
RU2129863C1 |
METHOD FOR PREVENTING PATHOLOGICAL PREGNANCY SYNDROME | 2015 |
|
RU2575789C1 |
METHOD FOR PREECLAMPSIA PREVENTION | 2011 |
|
RU2472506C1 |
METHOD FOR PREVENTING PLACENTAL DYSFUNCTION IN ACUTE GESTATIONAL PYELONEPHRITIS | 2018 |
|
RU2694514C1 |
METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
METHOD FOR PREVENTING GESTOSIS IN CASES OF HIGH RISK | 1998 |
|
RU2152201C1 |
Authors
Dates
2012-01-27—Published
2010-06-04—Filed